NasdaqGS:OMCLMedical Equipment
Omnicell (OMCL) Q1 EPS Recovery Tests Bullish Margin Improvement Narrative
Omnicell (OMCL) opened 2026 with Q1 revenue of US$309.9 million and basic EPS of US$0.25, alongside trailing twelve month revenue of about US$1.2 billion and EPS of US$0.45 that point to relatively slim profitability. Over the past year, the company has seen quarterly revenue range from US$269.7 million to US$314.0 million and basic EPS swing between a loss of US$0.15 and a profit of US$0.34, while trailing net margins have stayed low and a touch softer than the prior year. For investors,...